Parametric Portfolio Associates’s Clovis Oncology, Inc. CLVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$304K Buy
150,446
+33,552
+29% +$67.8K ﹤0.01% 3270
2021
Q4
$317K Buy
116,894
+20,674
+21% +$56.1K ﹤0.01% 3264
2021
Q3
$429K Buy
96,220
+5,384
+6% +$24K ﹤0.01% 3167
2021
Q2
$527K Buy
90,836
+14,658
+19% +$85K ﹤0.01% 3059
2021
Q1
$535K Buy
76,178
+33,203
+77% +$233K ﹤0.01% 3476
2020
Q4
$206K Buy
42,975
+12,443
+41% +$59.6K ﹤0.01% 3761
2020
Q3
$178K Sell
30,532
-70,810
-70% -$413K ﹤0.01% 3694
2020
Q2
$684K Buy
101,342
+66,376
+190% +$448K ﹤0.01% 3115
2020
Q1
$222K Buy
34,966
+2,566
+8% +$16.3K ﹤0.01% 3512
2019
Q4
$338K Buy
+32,400
New +$338K ﹤0.01% 3526
2019
Q3
Sell
-30,110
Closed -$448K 4025
2019
Q2
$448K Sell
30,110
-38,787
-56% -$577K ﹤0.01% 3406
2019
Q1
$1.71M Buy
68,897
+17,231
+33% +$428K ﹤0.01% 2742
2018
Q4
$928K Sell
51,666
-7,987
-13% -$143K ﹤0.01% 3031
2018
Q3
$1.75M Buy
59,653
+25,623
+75% +$753K ﹤0.01% 2803
2018
Q2
$1.55M Sell
34,030
-1,726
-5% -$78.5K ﹤0.01% 2834
2018
Q1
$1.89M Buy
35,756
+4,421
+14% +$233K ﹤0.01% 2660
2017
Q4
$2.13M Sell
31,335
-16,096
-34% -$1.09M ﹤0.01% 2563
2017
Q3
$3.91M Sell
47,431
-7,595
-14% -$626K ﹤0.01% 2066
2017
Q2
$5.15M Sell
55,026
-7,432
-12% -$696K 0.01% 1748
2017
Q1
$3.98M Buy
62,458
+37,237
+148% +$2.37M 0.01% 1956
2016
Q4
$1.12M Buy
25,221
+13,384
+113% +$594K ﹤0.01% 2767
2016
Q3
$427K Buy
11,837
+1,376
+13% +$49.6K ﹤0.01% 3243
2016
Q2
$144K Buy
+10,461
New +$144K ﹤0.01% 3675
2016
Q1
Sell
-6,498
Closed -$227K 4050
2015
Q4
$227K Sell
6,498
-13,169
-67% -$460K ﹤0.01% 3680
2015
Q3
$1.81M Buy
19,667
+2,196
+13% +$202K ﹤0.01% 1922
2015
Q2
$1.54M Sell
17,471
-827
-5% -$72.7K ﹤0.01% 2456
2015
Q1
$1.36M Sell
18,298
-2,558
-12% -$190K ﹤0.01% 2544
2014
Q4
$1.17M Buy
20,856
+478
+2% +$26.8K ﹤0.01% 2657
2014
Q3
$924K Buy
20,378
+8,984
+79% +$407K ﹤0.01% 2763
2014
Q2
$472K Sell
11,394
-7,506
-40% -$311K ﹤0.01% 3238
2014
Q1
$1.31M Buy
18,900
+1,042
+6% +$72.2K ﹤0.01% 2440
2013
Q4
$1.08M Buy
17,858
+7,050
+65% +$425K ﹤0.01% 2600
2013
Q3
$657K Buy
10,808
+6,496
+151% +$395K ﹤0.01% 2912
2013
Q2
$289K Buy
+4,312
New +$289K ﹤0.01% 3295